A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Chemical Inhibitor of the Skp2/p300 Interaction that Promotes p53-Mediated Apoptosis
Authors
Keywords
-
Journal
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
Volume 55, Issue 2, Pages 602-606
Publisher
Wiley
Online
2015-11-23
DOI
10.1002/anie.201508716
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Reversible and Highly Selective Inhibitor of the Proteasomal Ubiquitin Receptor Rpn13 Is Toxic to Multiple Myeloma Cells
- (2015) Darci J. Trader et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Modulators of Protein–Protein Interactions
- (2014) Lech-Gustav Milroy et al. CHEMICAL REVIEWS
- Small-Molecule Inhibitors of Protein-Protein Interactions: Progressing toward the Reality
- (2014) Michelle R. Arkin et al. CHEMISTRY & BIOLOGY
- SCF ubiquitin ligase-targeted therapies
- (2014) Jeffrey R. Skaar et al. NATURE REVIEWS DRUG DISCOVERY
- Facile Method To Sequence Cyclic Peptides/Peptoids via One-Pot Ring-Opening/Cleavage Reaction
- (2014) Kang Ju Lee et al. ORGANIC LETTERS
- Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated -synuclein
- (2014) M. Oh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression
- (2013) Chia-Hsin Chan et al. CELL
- Screening Bicyclic Peptide Libraries for Protein–Protein Interaction Inhibitors: Discovery of a Tumor Necrosis Factor-α Antagonist
- (2013) Wenlong Lian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Targeting protein–protein interactions as an anticancer strategy
- (2013) Andrei A. Ivanov et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Rational Design of Bioactive, Modularly Assembled Aminoglycosides Targeting the RNA that Causes Myotonic Dystrophy Type 1
- (2012) Jessica L. Childs-Disney et al. ACS Chemical Biology
- Acetylation-Dependent Regulation of Skp2 Function
- (2012) Hiroyuki Inuzuka et al. CELL
- The Skp2-SCF E3 Ligase Regulates Akt Ubiquitination, Glycolysis, Herceptin Sensitivity, and Tumorigenesis
- (2012) Chia-Hsin Chan et al. CELL
- Structural Biology and Drug Discovery of Difficult Targets: The Limits of Ligandability
- (2012) Sachin Surade et al. CHEMISTRY & BIOLOGY
- Specific Small Molecule Inhibitors of Skp2-Mediated p27 Degradation
- (2012) Lily Wu et al. CHEMISTRY & BIOLOGY
- Peptoids: Bio-Inspired Polymers as Potential Pharmaceuticals
- (2012) Michelle T. Dohm et al. CURRENT PHARMACEUTICAL DESIGN
- Identification of Candidate IgG Biomarkers for Alzheimer's Disease via Combinatorial Library Screening
- (2011) M. Muralidhar Reddy et al. CELL
- Design and Facile Solid-Phase Synthesis of Conformationally Constrained Bicyclic Peptoids
- (2011) Ji Hoon Lee et al. ORGANIC LETTERS
- A simple strategy for the construction of combinatorial cyclic peptoid libraries
- (2010) Ji Hoon Lee et al. CHEMICAL COMMUNICATIONS
- Peptoid Macrocycles: Making the Rounds with Peptidomimetic Oligomers
- (2010) Barney Yoo et al. CHEMISTRY-A EUROPEAN JOURNAL
- Targeting the p27 E3 ligase SCFSkp2 results in p27- and Skp2-mediated cell-cycle arrest and activation of autophagy
- (2008) Q. Chen et al. BLOOD
- Oncogenic properties and prognostic implications of the ubiquitin ligase Skp2 in cancer
- (2008) Dan D. Hershko CANCER
- Peptoid architectures: elaboration, actuation, and application
- (2008) Barney Yoo et al. CURRENT OPINION IN CHEMICAL BIOLOGY
- Skp2 Suppresses p53-Dependent Apoptosis by Inhibiting p300
- (2008) Mayumi Kitagawa et al. MOLECULAR CELL
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started